Figure 5 : Overlap of obesity and diabetes With Lilly and Novo Nordisk currently the only two companies with approved weight loss medications in the US and international markets, the companies generated a combined $32bn in the US market last year alone and almost another $10bn outside the US
Tirzepatide , on the other hand, is a dual-agonist, acting on both GLP-1 and GIP (glucose-dependent insulinotropic polypeptide) receptors
Visit The Wellness Spa in Orlando to receive top-quality care for weight management
The capsule format is tasteless, convenient, and titratable you dial in your dose based on body weight using the 1000mg/10 lbs protocol, round up or down based on your GI sensitivity, and take it 90120 minutes before your performance window
Jung H, Tittel SR, Schloot NC, et al
Note: Always consult a licensed healthcare professional before starting any weight loss medication